Results 171 to 180 of about 1,486,665 (306)
Deconstructing Pharmaceutical Prices in a Government-Controlled Market: A Hedonic Regression Analysis of B2G Procurement in Thailand. [PDF]
Thila J, Pholphirul P.
europepmc +1 more source
Oil prices and government bond risk premiums
International audienceThis article analyses the impact of oil price on bond risk premiums issued by emerging economies. No empirical study has yet focussed on the effects of the oil price on government bond risk premiums.
Alexandre, Herve +2 more
core
Abstract Fairness is a foundational and highly consequential construct in marketing, shaping purchase intentions, brand attitudes, complaints, boycotts, and word‐of‐mouth. Yet extant consumer research has largely concentrated on price fairness, leaving fairness across the rest of marketing strategy and the marketing mix comparatively underexplored ...
Elizabeth M. S. Friedman +1 more
wiley +1 more source
Kindling Hospital Competition to Control Costs. [PDF]
Pauly M, Tao C.
europepmc +1 more source
Our paper systematically reviews the intestinal structure, function, and microbiota of ostriches, along with strategies for improving their gut health. We analyze how these factors collectively influence intestinal homeostasis and ostrich welfare, emphasizing probiotics as a promising intervention to enhance gut health, boost population well‐being, and
Zi‐Qun Zhang +6 more
wiley +1 more source
Cross-country differences in household healthcare spending. [PDF]
Papanicolas I +3 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Dynamic copay health plans, AI-enabled price transparency, and member experience. [PDF]
Debbarma A, Dowd BE.
europepmc +1 more source
Aims This study aims to develop a structured list of value assessment criteria for drug repurposing (DR) projects designed to support consistent, evidence‐informed decision‐making by funders. The assessment criteria were developed within the REMEDi4ALL project, a multi‐stakeholder Horizon Europe funded initiative to advance DR and were validated ...
Dalma Hosszú +10 more
wiley +1 more source

